4.7 Article

Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans

Journal

BIOMEDICINE & PHARMACOTHERAPY
Volume 139, Issue -, Pages -

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2021.111568

Keywords

Antifungal activity; Candida albicans; Fluconazole; Asiatic acid; Potential mechanism

Funding

  1. Beijing Health Alliance Charitable Foundation, China [WS630A]
  2. Shandong Provincial Administration of Traditional Chinese Medicine of China [2017-166]

Ask authors/readers for more resources

This study found that Asiatic acid in combination with fluconazole had a synergistic effect on fluconazole-resistant Candida albicans both in vitro and in vivo. The combination reduced the minimum inhibitory concentration of fluconazole and inhibited hyphal growth, possibly through mechanisms such as inhibition of drug efflux pump and accumulation of reactive oxygen species. These findings provide new insights for overcoming drug resistance and offer potential for future development and application of Asiatic acid.
Candida albicans (C. albicans) infection remains a challenge to clinicians due to the limited available antifungals. With the widespread use of antifungals in the clinic, the drug resistance has been emerging continuously, especially fluconazole. Therefore, searching for new antifungals, active constituents of natural or traditional medicines, and approaches to overcome antifungals resistance is needed. This study investigated the activity of Asiatic acid (AA) alone and in combination with fluconazole (FLC) against C. albicans in vitro and in vivo. The in vitro studies indicated that the drug combination had a synergistic effect on FLC-resistant C. albicans, with fractional inhibitory concentration index (FICI) of 0.25. And when AA at the dose of 32 mu g/mL, the drug combination group could decrease the sessile minimum inhibitory concentration (sMIC) of FLC from > 1024 mu g/mL to 0.125-0.25 mu g/mL within 8 h against C. albicans biofilms, even with the FICI > 0.5. In vivo, the antifungal efficacy of AA used alone and in combination with FLC was evaluated by Galleria mellonella (G. mellonella) larvae. The drug combination group prolonged the survival rate and reduced tissue invasion of larvae infected with resistant C. albicans. Furthermore, mechanism studies indicated that the antifungal effects of AA in combination with FLC might be associated with the inhibition of drug efflux pump, the accumulation of reactive oxygen species (ROS) and the inhibition of hyphal growth. These findings might provide novel insights for overcoming drug resistance of C. albicans and bring new reference data for the development and application of AA in future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available